SMTL ID : 6xlx.1

Crystal structure of cancer-associated G301D mutant of U2AF65 bound to AdML splice site

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x U- U- DU- U- U- BRU- C- C: DNA/RNA (5'-R(P*UP*UP*(UD)P*UP*U)-D(P*(BRU))-R(P*CP*C)-3')(Non-covalent)

U-U-DU-U-U-BRU-C-C.1: 40 residues within 4Å: Chain A: R.9, R.13, Y.15, N.18, K.58, N.59, F.60, F.62, K.88, R.90, R.91, P.92, H.93, D.94, T.115, V.116, V.117, D.119, K.123, F.125, G.127, G.128, N.152, V.154, K.155, S.157, K.163, D.164, Y.165, F.167, K.191, K.192, L.193, L.194, Q.196, R.197, A.198, G.201, A.202, K.203 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:R.91, A:H.93 Water bridges: A:D.94 Salt bridges: A:K.58 pi-Stacking: A:Y.15, A:H.93

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Maji, D. et al., Representative cancer-associated U2AF2 mutations alter RNA interactions and splicing. J.Biol.Chem. (2020)

Release Date

2020-10-07

Peptides

Splicing factor U2AF 65 kDa subunit: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Splicing factor U2AF 65 kDa subunit